Literature DB >> 15135982

The biological effects of five feline IFN-alpha subtypes.

Susan L Baldwin1, Tim D Powell, Karen S Sellins, Steven V Radecki, J John Cohen, Michael J Milhausen.   

Abstract

IFN-alpha has been shown to induce both antiviral and antiproliferative activities in animals. This report describes the biological activity of five recently identified feline IFN-alpha subtypes expressed in the Chinese hamster ovary (CHO) cell line (rfeIFN-alpha1[CHO], rfeIFN-alpha2[CHO], rfeIFN-alpha3[CHO], rfeIFN-alpha5[CHO] and rfeIFN-alpha6[CHO]) and the feIFN-alpha6 subtype expressed in and purified from Pichia pastoris (rfeIFN-alpha6[P. pastoris]). The rfeIFN-alpha[CHO] subtypes were tested for antiviral activity against either Vesicular stomatitis virus (VSV) or feline calicivirus (FCV) infected feline embryonic fibroblast cell line (AH927) or Crandell feline kidney cell line (CRFK). Antiviral activity was induced against both VSV and FCV infected AH927 cells and VSV infected CRFK cells by all five of the rfeIFN-alpha[CHO] subtypes and rfeIFN-alpha6[P. pastoris]. In addition, the IFN-alpha inducible Mx gene (associated with antiviral activity) was upregulated in vivo 24 h following treatment with rfeIFN-alpha6[P. pastoris], compared to baseline levels seen prior to treatment. All of the rfeIFN-alpha[CHO] subtypes and rfeIFN-alpha6[P. pastoris] exhibited antiproliferative activity in the FeT-J cell line (an IL-2 independent feline T-cell line). Both necrosis and apoptosis were observed in rfeIFN-alpha6[P. pastoris]-treated FeT-J cells. The rfeIFN-alpha3[CHO] subtype consistently exhibited lower antiviral and antiproliferative activity compared to that observed with the other four rfeIFN-alpha[CHO] subtypes. In summary, this paper demonstrates that five previously described feIFN-alpha subtypes induce both antiviral and antiproliferative activities in vitro and are capable of upregulating the feMx gene in vivo. Copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135982     DOI: 10.1016/j.vetimm.2004.01.012

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  6 in total

1.  Identification of regions and residues in feline junctional adhesion molecule required for feline calicivirus binding and infection.

Authors:  Robert J Ossiboff; John S L Parker
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

2.  Effect of type-I interferon on retroviruses.

Authors:  Esperanza Gómez-Lucía; Victorio M Collado; Guadalupe Miró; Ana Doménech
Journal:  Viruses       Date:  2009-10-27       Impact factor: 5.048

3.  The innate antiviral immune system of the cat: molecular tools for the measurement of its state of activation.

Authors:  Céline Robert-Tissot; Vera L Rüegger; Valentino Cattori; Marina L Meli; Barbara Riond; Maria Alice Gomes-Keller; Andrea Vögtlin; Burghardt Wittig; Christiane Juhls; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

4.  Induction of a systemic antiviral state in vivo in the domestic cat with a class A CpG oligonucleotide.

Authors:  Céline Robert-Tissot; Marina L Meli; Barbara Riond; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Vet Immunol Immunopathol       Date:  2012-08-04       Impact factor: 2.046

5.  Gene cloning, sequencing, expression and biological activity of giant panda (Ailuropoda melanoleuca) interferon-alpha.

Authors:  Xue-Mei Tan; Yang Tang; Yun-Fei Yang; Hong-Mei Song; Yi-Zheng Zhang
Journal:  Mol Immunol       Date:  2007-03-07       Impact factor: 4.407

6.  Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega.

Authors:  Verena Hampel; Bianca Schwarz; Christine Kempf; Roberto Köstlin; Ulrike Schillinger; Helmut Küchenhoff; Nora Fenske; Thomas Brill; Johannes Hirschberger
Journal:  J Vet Intern Med       Date:  2007 Nov-Dec       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.